Cardiology Today -- Findings from a new study provide the first evidence that an angiotension-II receptor blocking agent may reduce progression of coronary atherosclerosis.
Cardiology Today -- Findings from a new study provide the first evidence that an angiotension-II receptor blocking agent may reduce progression of coronary atherosclerosis.